Immunohistochemical and immunofluorescence and flow cytometry staining demonstrated that the proportion of CD8+ T cells and IFN-γ+ CD8+ T cells in the tumor tissue increased after silencing PITPNC1 and FASN. This evidence concerns the gene CD8A and neoplasm.